Health

Maker of ALS drug pulls Relyvrio off the market, keeping a promise to patients : Shots

In college, Amylyx cofounders Josh Cohen and Justin Klee dreamed of finding a treatment for diseases like ALS. When their…

Read More »

Global methane emissions automatically detected in satellite imagery using AI

Methane is particularly targeted for curbing greenhouse gas emissions because its significant global-warming potential in the short term exceeds carbon…

Read More »

Study links sleep apnea severity during REM stage to verbal memory decline

A research team led by the University of California, Irvine has revealed the link between the frequency of sleep apnea…

Read More »

Is Your Doctor ‘Blue Zones’ Certified?

Blue Zones, an organization that studies regions around the world where people live longer, happier lives, has partnered with The…

Read More »

Alzheimer’s Risk and the APOE4 Gene

Studies have long shown that if you carry two copies of the apolipoprotein E (APOE) 4 gene, your chances of…

Read More »

Experts Watching Bird Flu Carefully in Case It Takes Off

May 14, 2024 – So far, the unexpected jump of bird flu to cattle has not emerged as a new…

Read More »

Artificial intelligence tool to improve heart failure care

UVA Health researchers have developed a powerful new risk assessment tool for predicting outcomes in heart failure patients. The researchers…

Read More »

Some brain cells age faster and are more prevalent in Alzheimer’s

Engineers at the University of California San Diego have discovered that some brain cells age more rapidly than others, and…

Read More »

People with more copies of ribosomal DNA may have higher risks of developing disease

Ribosomal DNA (rDNA) is present in hundreds of copies in the genome, but has not previously been part of genetic…

Read More »

Newly identified PET biomarker predicts success of immune checkpoint blockade therapy

The protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing…

Read More »
Back to top button